pharma
dog
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
News
when
Latest
Archive
by source
All Sources
Sources Page
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
15
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 3
tozorakimab
Acute Respiratory Failure
$AZN
ASTRAZENECA PLC
1
catalysts
Phase 3
(acetazolamide + dronabinol)
(acetazolamide [INN] + dronabinol)
Obstructive Sleep Apnea
$IXHL
Incannex Healthcare Inc.
0
catalysts
Phase 3
AD-109
(atomoxetine [INN] + oxybutynin)
Obstructive Sleep Apnea
Apnimed Inc
0
catalysts
131
Pain
89
Neurology
1
Phase 3
DB-2Q
ExoFlo
Acute Respiratory Distress Syndrome
Direct Biologics LLC
0
catalysts
Phase 3
VAX-31
Streptococcal Pneumonia
$PCVX
Vaxcyte, Inc.
0
catalysts
Phase 3
admilparant
Idiopathic Pulmonary Fibrosis
Bristol-Myers Squibb Co
0
catalysts
Phase 3
astegolimab
Chronic Obstructive Pulmonary Disease (COPD)
IL-33 receptor (ST2)
F. Hoffmann-La Roche Ltd
0
catalysts
Phase 3
camlipixant
Chronic Cough
P2X purinoceptor 3
$GSK
GSK plc
0
catalysts
Phase 3
dexamethasone sodium phosphate
SEMDEXA (dexamethasone sodium phosphate)
Ataxia-Telangiectasia (Louis-Bar Syndrome)
Glucocorticoid receptor
$QNCX
Quince Therapeutics, Inc.
0
catalysts
Phase 3
florensocatib
Bronchiectasis
Chiesi Farmaceutici SpA
0
catalysts
Phase 3
itepekimab
Chronic Obstructive Pulmonary Disease (COPD)
Interleukin-33
$REGN
REGENERON PHARMACEUTICALS, INC.
0
catalysts
Phase 3
nintedanib
NINTEDANIB (nintedanib)
Pterygium
Platelet-derived growth factor receptor
Vascular endothelial growth factor receptor
Cloudbreak Therapeutics LLC
0
catalysts
Phase 3
pneumococcal conjugate (21-valent) vaccine
Pneumonia
SK Bioscience Ltd
0
catalysts
Phase 3
tosatoxumab
Salvecin (tosatoxumab [INN])
Ventilator Associated Pneumonia (VAP)
Aridis Pharmaceuticals Inc
0
catalysts
Phase 3
verducatib
verducatib [INN]
Bronchiectasis
Boehringer Ingelheim International GmbH
0
catalysts
